Immunotherapy Prompts “Remarkable Response” in Sarcomatoid Pleural Mesothelioma
Japanese doctors are reporting a remarkable response from the immunotherapy drug nivolumab in a patient with sarcomatoid pleural mesothelioma. Sarcomatoid…
-
-
Surgery Extends Survival for Patients with Pleural Mesothelioma
Patients with pleural mesothelioma who choose to have surgery live longer than those who do not. This applies no matter… -
Targeted Radiotherapy for Mesothelioma May Extend Survival in the Right Patients
A meta-analysis conducted by some of the country’s top cancer researchers says targeted radiotherapy for mesothelioma can help some people… -
Second Line Mesothelioma Treatment Shot Down in New Study
Italian researchers say there is good news and bad news about a proposed second line mesothelioma treatment. The good news… -
Amazing Keytruda Case Study Offers Hope for Advanced Mesothelioma
Italian doctors are reporting an “impressive clinical response” in a recently published Keytruda case study. The case is encouraging news… -
Diagnosis | Scans | Surgery | Treatments
Predicting Unresectable Mesothelioma Prior to Surgery
Cancer researchers at Baylor have found an effective way to identify certain cases of unresectable mesothelioma without making an incision.… -
New Studies | Research | Surgery | Treatments
Deep Vein Thrombosis After Pleurectomy for Mesothelioma
The authors of a new study on deep vein thrombosis after pleurectomy say mesothelioma patients may be at special risk.… -
Injectable Pemetrexed for Mesothelioma Now Available for the First Time
The FDA has cleared injectable pemetrexed for mesothelioma after two drug companies settled a patent dispute over the medication in… -
Immunotherapy with ONCOS-102 Shows Promise for Mesothelioma
Early results are in on the latest trial of immunotherapy with ONCOS-102 and the news is good for pleural mesothelioma… -
Radical Surgery for Peritoneal Mesothelioma Boosts Survival
Patients who have radical surgery for peritoneal mesothelioma live longer than those who have non-surgical treatments. That is the conclusion…
